Newsletter - Banner

Breadcrumb

Navigation Menu

Asset Publisher

ResearchMatch brings researchers together

Sixteen new matches made, eight project funded: life sciences researchers meet data scientists

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

Engaging in Research on Aging: How trainees and researchers connect with the CLSA (Webinar) (June 30, 2020)

In this webinar, four panelists will share their personal insights and experiences with the CLSA, showcasing opportunities to engage with Canada’s largest platform for research on aging.

Webinar: Immunity in our community - how to stay safe in the age of COVID (June 17, 2020)

Immunity in our community - how to stay safe in the age of COVID. Since the onset of the COVID-19 pandemic, the main theme at the forefront of everyone’s mind has been safety.

COVID-19 pandemic: the need for privacy and digital contact tracing

RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Why do some non-smokers get COPD while many heavy smokers don’t?

A new study highlights a strong risk factor for COPD related to lung development

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Webinar: Coexisting with COVID - the new normal (June 10, 2020)

The MUHC Foundation is launching a new webinar series!

From PhD to Employee Forum generates insights and perspectives

Report shares participants’ solutions to career development challenges in the life sciences

Interim Leadership of the Research Institute of the MUHC

The Board of Directors of the RI-MUHC is pleased to announce the appointment of Dr. Miguel N. Burnier, Jr. to the position of Interim Executive Director and Chief Scientific Officer of the RI-MUHC

Made-in-Canada COVID-19 test developed at McGill receives government support

Government support for McGill and RI-MUHC team in COVID-19 testing

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

COVID-19 Q&A: Tina Montreuil on helping children cope with anxiety

“It is not only what you say that matters, but what you do”

Looking to produce a COVID-19 vaccine in the greenhouse

RI-MUHC researcher working with Quebec-based company on a plant-based technique

National study to collect data on aging adults’ experiences during COVID-19 pandemic

Christina Wolfson is co-principal investigator on a new national study

Ventilator Challenge: Three finalist teams announced

Results of the daring challenge to design a low-cost, easy-to-reproduce ventilator in two weeks

We Care About Rare!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

The RI-MUHC receives and tests the first UV-Disinfection robot in Canada

Novel robotics technology could potentially reduce healthcare-associated infections